Synapse - Glenn Kroog

Glenn Kroog

Research Focus

Former Employee. Medicine; Assistant Attending

3961

Recent additions – View all

A phase II randomized study of bortezomib/dexamethasone (Bort/Dex) with or without elotuzumab (Elo) in patients (pts) with relapsed/refractory multiple myeloma (RR MM) (CA204-009)
Meeting Abstract

Jakubowiak, A. J.; White, D.; Moreau, P.; Facon, T.; Vij, R.; Kroog, G. S.; Kopit, J.; Singhal, A.; Palumbo, A. P.
Journal of Clinical Oncology (2012)

Fulltext@MSK | Save
Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma
Journal Article

Molina, A. M.; Feldman, D. R.; Ginsberg, M. S.; Kroog, G.; Tickoo, S. K.; Jia, X.; Georges, M.; Patil, S.; Baum, M. S.; Reuter, V. E.; more...
Investigational New Drugs (2012)

Fulltext@MSK | Save
Nephrotoxicities associated with the use of tyrosine kinase inhibitors: A single-center experience and review of the literature
Journal Article

Jhaveri, K. D.; Flombaum, C. D.; Kroog, G.; Glezerman, I. G.
Nephron Clinical Practice (2011)

Fulltext@MSK | Save

Co-authors at MSK

3

Motzer
2

Feldman
2

Ginsberg
2

Patil
1

Baum
1

Fischer
1

Flombaum
1

Georges
1

Glezerman
1

Jia
1

Kondagunta
1

Leoce
1

Molina
1

Reuter
1

Tickoo
1

Trinos

Types of Work

Publications